GOLDMAN SACHS GROUP INC

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 886982 NEW YORK, NY

Position in CRBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$874,311

+$488,166 QoQ

Shares Held

93,111

+96.3% QoQ

Ownership

0.503%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. CRBP ranks #260 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,417,875	$1,079,677,898
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300,558	$1,004,863,129
3	MRNA	Moderna, Inc.	6,603,697	$335,467,805
4	ROIV	Roivant Sciences Ltd.	11,111,591	$307,791,069
5	PRAX	Praxis Precision Medicines, Inc.	710,734	$228,991,385
6	INCY	Incyte Corp	2,351,221	$221,296,919
7	RVMD	Revolution Medicines, Inc.	2,185,500	$212,539,874
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,965,432	$170,933,620

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$874,311	93,111	+96.3%	Shares	Defined	2026-05-15
2025-12-31	$386,145	47,438	+42.2%	Shares	Defined	2026-03-25
2025-09-30	$421,902	33,352	-23.6%	Shares	Defined	2025-11-14
2025-06-30	$301,350	43,674	-24.6%	Shares	Defined	2025-08-14
2025-03-31	$307,639	57,936	+1.3%	Shares	Defined	2025-06-27
2024-12-31	$674,653	57,174	+15.7%	Shares	Defined	2025-02-11
2024-09-30	$1,019,534	49,420	-18.4%	Shares	Defined	2024-11-14
2024-06-30	$2,738,892	60,528	-43.1%	Shares	Defined	2024-08-13
2024-03-31	$4,174,272	106,378	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.